These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26797792)

  • 1. Development and validation of the mastocytosis quality of life questionnaire: MC-QoL.
    Siebenhaar F; von Tschirnhaus E; Hartmann K; Rabenhorst A; Staubach P; Peveling-Oberhag A; Wagner N; Martus P; Carter MC; Metcalfe DD; Church MK; Maurer M; Weller K
    Allergy; 2016 Jun; 71(6):869-77. PubMed ID: 26797792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of the mastocytosis activity score.
    Siebenhaar F; Sander B; Ho LHT; Ellrich A; Maurer M; Weller K
    Allergy; 2018 Jul; 73(7):1489-1496. PubMed ID: 29405310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of the Cholinergic Urticaria Quality-of-Life Questionnaire (CholU-QoL).
    Ruft J; Asady A; Staubach P; Casale T; Sussmann G; Zuberbier T; Maurer M; Weller K; Altrichter S
    Clin Exp Allergy; 2018 Apr; 48(4):433-444. PubMed ID: 29369455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and construct validation of the angioedema quality of life questionnaire.
    Weller K; Groffik A; Magerl M; Tohme N; Martus P; Krause K; Metz M; Staubach P; Maurer M
    Allergy; 2012 Oct; 67(10):1289-98. PubMed ID: 22913638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translation and Cultural Adaptation of the German Mastocytosis Quality of Life Questionnaire (MC-QoL) into Spanish.
    Bertolín-Colilla M; Garin-Boronat O; Siebenhaar F; Maurer M; Pujol RM; Giménez-Arnau AM
    Actas Dermosifiliogr (Engl Ed); 2020 Apr; 111(3):243-248. PubMed ID: 31987469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-Related Quality of Life and Influencing Factors in Adults with Nonadvanced Mastocytosis-A Cross-Sectional Study and Qualitative Approach.
    Pulfer S; Ziehfreund S; Gebhard J; Hindelang B; Biedermann T; Brockow K; Zink A
    J Allergy Clin Immunol Pract; 2021 Aug; 9(8):3166-3175.e2. PubMed ID: 33965596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of lirentelimab in patients with refractory indolent systemic mastocytosis: a first-in-human clinical trial.
    Siebenhaar F; Altrichter S; Bonnekoh H; Hawro T; Hawro M; Michaelis EG; Kantor AM; Chang AT; Youngblood BA; Singh B; Rasmussen HS; Maurer M
    Br J Dermatol; 2023 Oct; 189(5):511-519. PubMed ID: 37290787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported disease-specific quality-of-life and symptom severity in systemic mastocytosis.
    van Anrooij B; Kluin-Nelemans JC; Safy M; Flokstra-de Blok BM; Oude Elberink JN
    Allergy; 2016 Nov; 71(11):1585-1593. PubMed ID: 27089859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF) in a phase 2 clinical study.
    Padilla B; Shields AL; Taylor F; Li X; Mcdonald J; Green T; Boral AL; Lin HM; Akin C; Siebenhaar F; Mar B
    Orphanet J Rare Dis; 2021 Oct; 16(1):434. PubMed ID: 34663404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mastocytosis Society survey on mast cell disorders: patient experiences and perceptions.
    Jennings S; Russell N; Jennings B; Slee V; Sterling L; Castells M; Valent P; Akin C
    J Allergy Clin Immunol Pract; 2014; 2(1):70-6. PubMed ID: 24565772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.
    Alvarez-Twose I; Zanotti R; González-de-Olano D; Bonadonna P; Vega A; Matito A; Sánchez-Muñoz L; Morgado JM; Perbellini O; García-Montero A; De Matteis G; Teodósio C; Rossini M; Jara-Acevedo M; Schena D; Mayado A; Zamò A; Mollejo M; Sánchez-López P; Cabañes N; Orfao A; Escribano L; ;
    J Allergy Clin Immunol; 2014 Feb; 133(2):520-8. PubMed ID: 23921094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a condition-specific measure for chronic periodontitis: Oral health impact profile for chronic periodontitis.
    He S; Wang J; Wei S; Ji P
    J Clin Periodontol; 2017 Jun; 44(6):591-600. PubMed ID: 28278366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis.
    Hartmann K; Gotlib J; Akin C; Hermine O; Awan FT; Hexner E; Mauro MJ; Menssen HD; Redhu S; Knoll S; Sotlar K; George TI; Horny HP; Valent P; Reiter A; Kluin-Nelemans HC
    J Allergy Clin Immunol; 2020 Aug; 146(2):356-366.e4. PubMed ID: 32437738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Food-related Quality of Life in Inflammatory Bowel Disease: Development and Validation of a Questionnaire.
    Hughes LD; King L; Morgan M; Ayis S; Direkze N; Lomer MC; Lindsay JO; Whelan K
    J Crohns Colitis; 2016 Feb; 10(2):194-201. PubMed ID: 26507859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium.
    Pyatilova P; Akin C; Alvarez-Twose I; Arock M; Bonadonna P; Brockow K; Butterfield JH; Broesby-Olsen S; Carter MC; Castells M; George TI; Gotlib J; Greiner G; Gülen T; Hartmann K; Hermine O; Horny HP; Jawhar M; Lange M; Lyons JJ; Maurer M; Metcalfe DD; Nedoszytko B; Niedoszytko M; Orfao A; Reiter A; Schwaab J; Sotlar K; Sperr WR; Triggiani M; Valent P; Siebenhaar F
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2015-2024. PubMed ID: 35724950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adult eosinophilic oesophagitis quality of life questionnaire: a new measure of health-related quality of life.
    Taft TH; Kern E; Kwiatek MA; Hirano I; Gonsalves N; Keefer L
    Aliment Pharmacol Ther; 2011 Oct; 34(7):790-8. PubMed ID: 21806649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life after pulmonary embolism: Prospective validation of the German version of the PEmb-QoL questionnaire.
    Frey PM; Méan M; Limacher A; Leiss W; Schwab N; Rochat M; Aujesky D
    Thromb Res; 2015 Jun; 135(6):1087-92. PubMed ID: 25887632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of pregnancy in mastocytosis: a study of the Spanish Network on Mastocytosis (REMA) in 45 cases.
    Matito A; Álvarez-Twose I; Morgado JM; Sánchez-Muñoz L; Orfao A; Escribano L
    Int Arch Allergy Immunol; 2011; 156(1):104-11. PubMed ID: 21447966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Initial Validation of a Questionnaire to Measure Health-Related Quality of Life of Adults with Common Variable Immune Deficiency: The CVID_QoL Questionnaire.
    Quinti I; Pulvirenti F; Giannantoni P; Hajjar J; Canter DL; Milito C; Abeni D; Orange JS; Tabolli S
    J Allergy Clin Immunol Pract; 2016; 4(6):1169-1179.e4. PubMed ID: 27665385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a disease-specific quality of life questionnaire for gastro-oesophageal reflux disease: the GERD-QOL questionnaire.
    Chan Y; Ching JY; Cheung CM; Tsoi KK; Polder-Verkiel S; Pang SH; Quan WL; Kee KM; Chan FK; Sung JJ; Wu JC
    Aliment Pharmacol Ther; 2010 Feb; 31(3):452-60. PubMed ID: 19878152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.